Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Virology|August 21, 2007
Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrixAjay K Bhatia, Nancy Campbell, Antonito Panganiban, et al.
Virology|December 9, 2008
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tailAjay K Bhatia, Rajnish Kaushik, Nancy A Campbell, et al.
The International Journal of Artificial Organs|December 29, 2020
Measures of anticoagulation and coagulopathy in pediatric cardiac extracorporeal membrane oxygenation patientsMouhammad Yabrodi, Carrie Ciccotello, Ajay K Bhatia, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 7, 2016
Detection of blur artifacts in histopathological whole-slide images of endomyocardial biopsiesHang Wu, John H Phan, Ajay K Bhatia, et al.
World Journal of Cardiology|October 31, 2017
Utility and correlation of known anticoagulation parameters in the management of pediatric ventricular assist devicesAjay K Bhatia, Mouhammad Yabrodi, Mallory Carroll, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2024
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label StudiesFrederick J Raal, Robert A Hegele, Andrea Ruzza, et al.
Headache|October 14, 2025
Comprehensive assessment of erenumab efficacy in participants with high-frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE studyGabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, et al.
European Journal of Preventive Cardiology|November 12, 2024
Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemiaAlbert Wiegman, Andrea Ruzza, G Kees Hovingh, et al.
American Heart Journal|December 31, 2023
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trialErin A Bohula, Nicholas A Marston, Andrea Ruzza, et al.
European Journal of Preventive Cardiology|October 19, 2023
Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatmentRaul D Santos, Andrea Ruzza, Bei Wang, et al.
Pageof 2